Nuveen Asset Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $49.2 Million - $57.5 Million	-496,973 Reduced 36.91%	849,393 $98.3 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $37.6 Million - $43.9 Million	-390,592 Reduced 22.49%	1,346,366 $138 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $314 Million - $332 Million	-2,921,685 Reduced 62.72%	1,736,958 $190 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $143 Million - $261 Million	-2,295,927 Reduced 33.01%	4,658,643 $530 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $2.43 Million - $3.49 Million	-41,263 Reduced 0.59%	6,954,570 $430 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $25.2 Million - $37 Million	317,874 Added 4.76%	6,995,833 $558 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $31.8 Million - $40.4 Million	-367,464 Reduced 5.22%	6,677,959 $726 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $16.9 Million - $20.6 Million	171,736 Added 2.5%	7,045,423 $759 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $187 Million - $225 Million	2,038,214 Added 42.15%	6,873,687 $753 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $95 Million - $106 Million	1,101,710 Added 29.51%	4,835,473 $453 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $37.6 Million - $50 Million	523,312 Added 16.3%	3,733,763 $344 Million
Q4 2020 May 17, 2021	BUY	$67.0 - $84.39 $12.1 Million - $15.3 Million	180,864 Added 5.97%	3,210,451 $235 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $14.5 Million - $18.3 Million	-216,549 Reduced 6.67%	3,029,587 $222 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $34.8 Million - $50.3 Million	629,552 Added 24.06%	3,246,136 $252 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $14.9 Million - $28.2 Million	494,796 Added 23.32%	2,616,584 $145 Million
Q1 2020 May 14, 2020	SELL	$24.87 - $38.56 $19.1 Million - $29.6 Million	-768,123 Reduced 26.58%	2,121,788 $62.8 Million
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $1.63 Million - $2.35 Million	-63,978 Reduced 2.17%	2,889,911 $105 Million
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $29.5 Million - $35.8 Million	1,281,050 Added 76.58%	2,953,889 $80.4 Million
Q2 2019 Aug 15, 2019	BUY	$22.81 - $28.48 $38.2 Million - $47.6 Million	1,672,839 New	1,672,839 $40.2 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account